Literature DB >> 31506891

Bullous Diseases in Children: A Review of Clinical Features and Treatment Options.

Brittney Schultz1,2, Kristen Hook3,4.   

Abstract

Bullous diseases are uncommon in children; however, as they have the potential to affect quality of life, occasionally have long-term side effects in the setting of scarring processes, and carry a rare risk of underlying malignancy [e.g., with paraneoplastic pemphigus (PNP)], knowledge of their clinical presentation and treatment options is essential. Given the rarity of these conditions, our current state of knowledge is largely derived from case reports and case series, with a paucity of evidence-based recommendations. In this review, we discuss the clinical presentation of and treatment options for linear immunoglobulin A disease, dermatitis herpetiformis, pemphigus vulgaris, pemphigus foliaceus, PNP, bullous pemphigoid, mucus membrane pemphigoid, epidermolysis bullosa acquisita, and inherited epidermolysis bullosa. In general, when these conditions, except for PNP, occur in childhood, they have a better prognosis than when they occur in adults. Clinical, histopathological, and immunologic features frequently overlap, but distinct differences have also been reported, most commonly in clinical presentation. Treatment is often similar to that in adults, although specific considerations are necessary for a pediatric population.

Entities:  

Mesh:

Year:  2019        PMID: 31506891     DOI: 10.1007/s40272-019-00349-3

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  109 in total

1.  Pemphigus foliaceus.

Authors:  H O PERRY
Journal:  Arch Dermatol       Date:  1961-01

2.  Anti-p200 pemphigoid in a 17-year-old girl successfully treated with systemic corticosteroid and dapsone.

Authors:  N Yamane; D Sawamura; W Nishie; M Abe; K Kodama; K Adachi; H Nakamura; N Ishii; T Hashimoto; H Shimizu
Journal:  Br J Dermatol       Date:  2007-03-23       Impact factor: 9.302

Review 3.  Dermatitis herpetiformis. Part II. Diagnosis, management, and prognosis.

Authors:  Diana Bolotin; Vesna Petronic-Rosic
Journal:  J Am Acad Dermatol       Date:  2011-06       Impact factor: 11.527

Review 4.  Juvenile IgA pemphigus: A case report and review of literature.

Authors:  Kanagala Chowdary Neethu; Raghavendra Rao; C Balachandran; Sathish Pai
Journal:  Indian J Dermatol Venereol Leprol       Date:  2016 Jul-Aug       Impact factor: 2.545

Review 5.  Image Gallery: Juvenile autoimmune pemphigus presenting with diffuse gingival hypertrophy and antibodies against desmocollin 3.

Authors:  J S Leventhal; C M Haberland; S E Cowper; M M Tomayko
Journal:  Br J Dermatol       Date:  2017-11       Impact factor: 9.302

6.  Rituximab Treatment for Recalcitrant Dermatitis Herpetiformis.

Authors:  Lauren N Albers; John J Zone; Benjamin K Stoff; Ron J Feldman
Journal:  JAMA Dermatol       Date:  2017-03-01       Impact factor: 10.282

7.  Clinical and immunopathological features of 159 patients with dermatitis herpetiformis: an Italian experience.

Authors:  E Antiga; A Verdelli; A Calabrò; P Fabbri; M Caproni
Journal:  G Ital Dermatol Venereol       Date:  2013-04       Impact factor: 2.011

Review 8.  Bullous pemphigoid in infancy: Clinical and epidemiologic characteristics.

Authors:  Orith Waisbourd-Zinman; Dani Ben-Amitai; Arnon D Cohen; Meora Feinmesser; Daniel Mimouni; Ayelet Adir-Shani; Marina Zlotkin; Alex Zvulunov
Journal:  J Am Acad Dermatol       Date:  2007-10-22       Impact factor: 11.527

Review 9.  Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients.

Authors:  Daryl R Cheng; Rebecca Barton; Anthea Greenway; Nigel W Crawford
Journal:  Expert Rev Vaccines       Date:  2016-06-13       Impact factor: 5.217

10.  Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases.

Authors:  Aniek Lamberts; H Ilona Euverman; Jorrit B Terra; Marcel F Jonkman; Barbara Horváth
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

View more
  5 in total

1.  Epidermolysis bullosa acquisita.

Authors:  Denise Miyamoto; Juliana Olivieri Gordilho; Claudia Giuli Santi; Adriana Maria Porro
Journal:  An Bras Dermatol       Date:  2022-06-11       Impact factor: 2.113

2.  Bullous Pemphigoid in Three Paediatric Patients in Finland.

Authors:  Anna Pankakoski; Jaana Panelius; Alexander Salava; Nicolas Kluger
Journal:  Acta Derm Venereol       Date:  2020-03-18       Impact factor: 3.875

Review 3.  Linear Immunoglobulin a Bullous Dermatosis in Children.

Authors:  Francesca Mori; Francesca Saretta; Lucia Liotti; Mattia Giovannini; Riccardo Castagnoli; Stefania Arasi; Simona Barni; Carla Mastrorilli; Luca Pecoraro; Lucia Caminiti; Gian Luigi Marseglia; Annick Barbaud; Elio Novembre
Journal:  Front Pediatr       Date:  2022-07-08       Impact factor: 3.569

4.  Acral blisters in neonates: Three rare and benign diseases.

Authors:  Mariem Rekik; Chiraz Regaieg; Khadija Sellami; Habiba Khanfir; Nadia Kolsi; Massara Baklouti; Mariem Amouri; Abderrahman Masmoudi; Afef Ben Thabet; Abdellatif Gargouri; Hamida Turki
Journal:  Clin Case Rep       Date:  2022-10-11

Review 5.  Risk Factors for Mucosal Involvement in Bullous Pemphigoid and the Possible Mechanism: A Review.

Authors:  Xinyi Chen; Wenlin Zhao; Hongzhong Jin; Li Li
Journal:  Front Med (Lausanne)       Date:  2021-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.